Interestingly, the potential for Chk1 and Wee1 inhibition to function in combination with PBT in radiosensitising HNSCC cells are currently lacking, and particularly to assess whether there is any impact of LET on the cellular response. The gene discussed is WEE1; the disease is head and neck squamous cell carcinoma.